This site is a comprehensive resource for biotech enthusiasts, including investors, researchers, media, etc. You'll find information about drug discovery and development, the FDA approval process, and loads of links and information about specific drugs and biotech companies.
BiotechDueDiligence's Latest Posts
You know the drill by now - enjoy the latest batch of biotech-themed tweets that captured the week that was, courtesy of @23aloha. Featured tickers: $ABBV $ACAD $ACHN $ADHD $AGIO $BLUE $CELG $CERS $EXAS $GILD $KITE $NLNK $NPSP $RGLS $SHPG $TGTX $VRTX This is one of those days where it's worthwhile to look at your red stocks and seriously think about if there is something wrong with them.— Brad Loncar (@bradloncar) October 20, 2014 $ABBV and $SHPG kaput. $1.64B breakup fee. […]
Compound Properties: Starting a RenunciationDerek Lowe (In the Pipeline)The Empire of Edge: How a doctor, a trader, and the billionaire Steven A. Cohen got entangled in a vast financial scandal.Patrick Radden Keefe (The New Yorker)Cellular Immunotherapy & Unum Therapeutics: Out of Many, OneBruce Booth (LifeSci VC)Great perspective along with the news of another entrant into the CAR-T space along with Novartis, Kite, Juno, etc.Authors retract green coffee bean diet paper touted by […]
Part 2 of this week's double dose of biotech / pharma Twitter highlights here at BiotechDueDiligence. Thanks for checking out this new feature, and we welcome any feedback! Major credit as always due to @23aloha. Featured tickers: $ABBV $AGIO $ALNY $AMRN $ARWR $CEMP $CRDC $ESPR $FMI $GILD $ISRG $NSPH $PPHM $PSDV $SHPG $SNSS @ashishkjha Amazing thing about 'missteps in medicine' is that it tends to cluster and cascade. Just like excellence.— Amitabh Chandra (@amitabhchandra2) […]
A little late, but what a week it was! Enjoy this round-up of biotech-related tweets that captured the moment. Thanks as always to @23aloha for the lion's share of the curation duties. Featured tickers: $ARWR $BLUE $BMY $DRTX $GILD $KITE $PFE $SNSS $SRPT $ZIOP $IBB $XBI What's missing from brouhaha over drug pricing? Congress chose NOT to give the CMS negotiating power on prices. $PFE Kindler's last hurrah— Sally Church (@MaverickNY) October 6, 2014 Happy for […]
Artificial sweeteners induce glucose intolerance by altering the gut microbiotaSuez et al. Nature.Patient-Contributed Tumor Genetics Data: A Pathway to Better Drug DevelopmentBenita et al. AJMC.Reversion of advanced Ebola virus disease in nonhuman primates with ZMappQiu et al. Nature.Ice bucket challenge cash may help derisk ALS drug researchManasi Vaidya. Nature Medicine.Development of the clinical next-generation sequencing industry in a shifting policy climateCurnutte et al. Nature […]
Log in to leave a comment